KR20250109788A - 근시 진행의 치료 - Google Patents

근시 진행의 치료

Info

Publication number
KR20250109788A
KR20250109788A KR1020257022145A KR20257022145A KR20250109788A KR 20250109788 A KR20250109788 A KR 20250109788A KR 1020257022145 A KR1020257022145 A KR 1020257022145A KR 20257022145 A KR20257022145 A KR 20257022145A KR 20250109788 A KR20250109788 A KR 20250109788A
Authority
KR
South Korea
Prior art keywords
ophthalmic composition
copper
composition
agent
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257022145A
Other languages
English (en)
Korean (ko)
Inventor
랜든 마이클 버
발라무랄리 케이. 암바티
사라 에이. 몰로키아
Original Assignee
유니버시티 오브 유타 리서치 파운데이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 유타 리서치 파운데이션 filed Critical 유니버시티 오브 유타 리서치 파운데이션
Publication of KR20250109788A publication Critical patent/KR20250109788A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020257022145A 2018-01-05 2019-01-07 근시 진행의 치료 Pending KR20250109788A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862614230P 2018-01-05 2018-01-05
US62/614,230 2018-01-05
KR1020207022632A KR102831250B1 (ko) 2018-01-05 2019-01-07 근시 진행의 치료
PCT/US2019/012501 WO2019136358A1 (en) 2018-01-05 2019-01-07 Treatment of myopic progression

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020207022632A Division KR102831250B1 (ko) 2018-01-05 2019-01-07 근시 진행의 치료

Publications (1)

Publication Number Publication Date
KR20250109788A true KR20250109788A (ko) 2025-07-17

Family

ID=67143996

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020257022145A Pending KR20250109788A (ko) 2018-01-05 2019-01-07 근시 진행의 치료
KR1020207022632A Active KR102831250B1 (ko) 2018-01-05 2019-01-07 근시 진행의 치료

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020207022632A Active KR102831250B1 (ko) 2018-01-05 2019-01-07 근시 진행의 치료

Country Status (8)

Country Link
US (2) US11524032B2 (https=)
EP (1) EP3735209A4 (https=)
JP (3) JP7324208B2 (https=)
KR (2) KR20250109788A (https=)
CN (1) CN112105320A (https=)
AU (2) AU2019205774B2 (https=)
CA (1) CA3087622A1 (https=)
WO (1) WO2019136358A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11065275B2 (en) * 2016-03-08 2021-07-20 University Of Utah Research Foundation Cross-linking agents and associated methods
KR20250109788A (ko) * 2018-01-05 2025-07-17 유니버시티 오브 유타 리서치 파운데이션 근시 진행의 치료
CA3146848A1 (en) * 2019-07-11 2021-01-14 University Of Utah Research Foundation Multi-agent ocular formulations and treatment methods
TW202245810A (zh) * 2021-02-01 2022-12-01 美商艾維娜傳送系統公司 散光之治療
TW202302121A (zh) * 2021-02-11 2023-01-16 猶他大學研究基金會 近視之治療
CN115282349A (zh) * 2022-07-05 2022-11-04 复旦大学附属眼耳鼻喉科医院 一种有利于改善孟加拉玫瑰红-绿光角膜胶原交联技术中cct降低的角膜交联试剂
CN115386105B (zh) * 2022-08-26 2024-03-22 昆明理工大学 多重酶活性纳米酶荧光水凝胶的制备方法及应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416530A (en) 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
DE68913995T2 (de) 1989-09-27 1994-08-25 Mo Ni Skij I Glaznych Boleznej Zusammensetzung zur behandlung progressiver myopie.
EP1159941A3 (en) * 1991-10-15 2003-09-17 Ista Pharmaceuticals, Inc. Formulations for use in enzyme-orthokeratology
CN1047523C (zh) * 1993-11-23 1999-12-22 华中理工大学 一种防治近视的滴眼液
AU7488898A (en) 1997-05-16 1998-12-08 Corrective Vision, Inc. Improved contact lens
BR9908692A (pt) * 1998-03-09 2001-12-04 Ista Pharmaceuticals Inc Uso de agentes de enrijecimento corneal emortocerotologia enzimática
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
CA2443244A1 (en) * 2001-04-13 2002-10-24 Incyte Genomics, Inc. Enzymes
IL158904A0 (en) 2001-05-25 2004-05-12 Valley Forge Pharmaceuticals Pirenzepine ophthalmic gel
NZ540885A (en) * 2002-12-20 2009-02-28 Chakshu Res Inc Ophthalmic formulation for the prevention and treatment of ocular conditions
CN1518981A (zh) * 2003-07-23 2004-08-11 复旦大学附属眼耳鼻喉科医院 一种治疗近视的外用滴眼制剂
MXPA03011987A (es) * 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
WO2006055526A2 (en) 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
US20060276777A1 (en) * 2005-04-08 2006-12-07 Coroneo Minas T Corneal shaping
US20080014278A1 (en) 2006-06-30 2008-01-17 Nucryst Pharmaceuticals Metal-containing formulations and methods of use
WO2012161655A1 (en) 2011-05-23 2012-11-29 Singapore Health Services Pte Ltd Composition and/or method for reducing and/or preventing myopia progression comprising atropine
US20140343480A1 (en) * 2013-05-19 2014-11-20 Avedro, Inc. Systems, methods, and compositions for cross-linking
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости
WO2015155117A1 (en) * 2014-04-09 2015-10-15 Universität Leipzig A device for a medical treatment of a sclera
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
CN107530324A (zh) * 2015-04-09 2018-01-02 雷伯瑞特里巴达西公司 用于眼科用途的吡咯烷酮羧酸（pca）
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
US11065275B2 (en) 2016-03-08 2021-07-20 University Of Utah Research Foundation Cross-linking agents and associated methods
AU2018371787A1 (en) 2017-11-21 2020-11-05 Sydnexis, Inc. Ophthalmic composition and delivery device thereof
KR20250109788A (ko) * 2018-01-05 2025-07-17 유니버시티 오브 유타 리서치 파운데이션 근시 진행의 치료
CA3146848A1 (en) * 2019-07-11 2021-01-14 University Of Utah Research Foundation Multi-agent ocular formulations and treatment methods
TW202245810A (zh) * 2021-02-01 2022-12-01 美商艾維娜傳送系統公司 散光之治療
TW202302121A (zh) * 2021-02-11 2023-01-16 猶他大學研究基金會 近視之治療

Also Published As

Publication number Publication date
JP7655988B2 (ja) 2025-04-02
CA3087622A1 (en) 2019-07-11
EP3735209A1 (en) 2020-11-11
AU2019205774B2 (en) 2025-01-02
US12544400B2 (en) 2026-02-10
AU2024278182A1 (en) 2025-01-02
KR20200118426A (ko) 2020-10-15
WO2019136358A1 (en) 2019-07-11
US20230256012A1 (en) 2023-08-17
KR102831250B1 (ko) 2025-07-08
US11524032B2 (en) 2022-12-13
JP2025111434A (ja) 2025-07-30
AU2019205774A1 (en) 2020-08-06
US20210060059A1 (en) 2021-03-04
CN112105320A (zh) 2020-12-18
JP2023153905A (ja) 2023-10-18
JP2021509902A (ja) 2021-04-08
JP7324208B2 (ja) 2023-08-09
EP3735209A4 (en) 2021-09-08

Similar Documents

Publication Publication Date Title
KR102831250B1 (ko) 근시 진행의 치료
AU2023202236B2 (en) Cross-linking agents and associated methods
AU2020311441B2 (en) Multi-agent ocular formulations and treatment methods
US20240122974A1 (en) Treatment of myopia
HK40107891A (en) Cross-linking agents and associated methods

Legal Events

Date Code Title Description
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-NAP-PG1501 (AS PROVIDED BY THE NATIONAL OFFICE)